Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use
The ethical risks of off-label clinical use of drugs include many risks, incomplete laws and regulations, difficulties in risk-benefit assessment, and challenges in managing conflict of interest management and obtaining informed consent. There are no clear regulations in China that require ethics co...
Saved in:
Main Authors: | Xuelian TANG, Jue WU, Xiaoyan LI, Jiyin ZHOU |
---|---|
Format: | Article |
Language: | Chinese |
Published: |
Editorial Office of Medicine and Philosophy
2025-02-01
|
Series: | Yixue yu zhexue |
Subjects: | |
Online Access: | https://yizhe.dmu.edu.cn/article/doi/10.12014/j.issn.1002-0772.2025.04.06 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01) -
Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01) -
Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
by: S. R. Gilyarevskiy
Published: (2020-05-01) -
The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01) -
Legal and Medical Aspects of Off-Label Medication Use. Point of View
by: O. V. Tsygankova, et al.
Published: (2019-03-01)